Literature DB >> 10468806

The treatment of acne fulminans: a review of 25 cases.

D C Seukeran1, W J Cunliffe.   

Abstract

The treatment of acne fulminans has been difficult. It is difficult to perform a controlled treatment trial due to the rarity of the complication. However, it is possible to compare four different therapeutic regimens which have evolved with time in the management of 25 patients over a period of 25 years. Oral antibiotics produced a slow response in the resolution of acne and systemic symptoms. The addition of a systemic steroid produced a quick resolution of systemic features, but the time until resolution of the acne was longer than when it was used in combination with oral isotretinoin. The protocols which used a combination of prednisolone and isotretinoin led to faster control of systemic features as well as clearance of acne when compared with other protocols. This was particularly so if the oral steroid was used sooner rather than later. We conclude that the preferred treatment of acne fulminans is oral prednisolone 0.5-1 mg/kg daily for 4-6 weeks (thereafter slowly reduced to zero) with oral isotretinoin being added to the regimen at the fourth week, initially at 0.5 mg/kg daily and gradually increased to achieve complete clearance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468806     DOI: 10.1046/j.1365-2133.1999.02982.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Zileuton, a new efficient and safe systemic anti-acne drug.

Authors:  Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-05

2.  Acne Fulminans Induced by Lymecycline in a Patient with Hidradenitis Suppurativa: A Case Report.

Authors:  Ilaria Trave; Claudia Micalizzi; Mattia Molle; Riccardo Castelli; Emanuele Cozzani; Aurora Parodi
Journal:  Case Rep Dermatol       Date:  2022-05-09

3.  Successful Treatment of Facial Acne Fulminans: Antimicrobial Agents and Oral Prednisolone as Promising Regimes.

Authors:  Amir Hossein Siadat; Anis Bostakian; Bahareh Abtahi-Naeini; Masoom Shahbazi
Journal:  Case Rep Dermatol Med       Date:  2017-03-27

4.  Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case.

Authors:  Claudio Marasca; Gabriella Fabbrocini; Luisa Abategiovanni; Elisa Camela; Mariateresa Nocerino; Adriana Di Guida; Gaia De Fata Salvatores
Journal:  Skin Appendage Disord       Date:  2021-01-21

5.  Pseudo-acne fulminans associated with oral isotretinoin.

Authors:  Luciana Rosa Grando; Oriete Gerin Leite; Tania Ferreira Cestari
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.